| Name | Arkansas Health Center |
|---|---|
| Location | 6701 Hwy 67, Benton, Arkansas |
| Certified By | Medicaid |
| No. of Certified Beds | 290 |
| Occupancy Rate | 74.52% |
| Medicare ID (CCN) | 04A293 |
| Legal Business Name | Legal Business Name Not Available |
| Ownership Type | Government - State |
| NPI Number | 1528128055 |
| Organization Name | ARKANSAS HEALTH CENTER |
| Doing Business As | BENTON SERVICES CENTER |
| Address | 6701 Hwy 67, Benton, AR 72015 |
| Phone Number | 501-860-0500 |
News Archive
Implanting blue light-filtering intraocular lenses during cataract surgery helps maintain visual function and may preserve the health of the retina, specifically in disease states such as age-related macular degeneration, according to a comprehensive review published in the May/June 2010 edition of Survey of Ophthalmology.
University of Chicago Medicine researchers have built a model system that uses multiple cell types from patients to rapidly test compounds that could block the early steps in ovarian cancer metastasis. Their three-dimensional cell-culture system, adapted for high-throughput screening, has enabled them to identify small molecules that can inhibit adhesion and invasion, preventing ovarian cancers from spreading to nearby tissues.
PRI's "The World" reports on an epidemic of an unexplained kidney disease that is affecting rural workers across Central America, writing, "[I]t's the second biggest cause of death among men in El Salvador, and in Nicaragua it's a bigger killer of men than HIV and diabetes combined," and "the latest theory is that the victims are literally working themselves to death."
AstraZeneca's new oral syk inhibitor, fostamatinib (R788), recently in-licensed from Rigel Pharmaceuticals, Inc., significantly improved outcomes of patients with rheumatoid arthritis who responded inadequately to ongoing treatment with methotrexate, according to phase II study data published in The New England Journal of Medicine today.
› Verified 1 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Implanting blue light-filtering intraocular lenses during cataract surgery helps maintain visual function and may preserve the health of the retina, specifically in disease states such as age-related macular degeneration, according to a comprehensive review published in the May/June 2010 edition of Survey of Ophthalmology.
University of Chicago Medicine researchers have built a model system that uses multiple cell types from patients to rapidly test compounds that could block the early steps in ovarian cancer metastasis. Their three-dimensional cell-culture system, adapted for high-throughput screening, has enabled them to identify small molecules that can inhibit adhesion and invasion, preventing ovarian cancers from spreading to nearby tissues.
PRI's "The World" reports on an epidemic of an unexplained kidney disease that is affecting rural workers across Central America, writing, "[I]t's the second biggest cause of death among men in El Salvador, and in Nicaragua it's a bigger killer of men than HIV and diabetes combined," and "the latest theory is that the victims are literally working themselves to death."
AstraZeneca's new oral syk inhibitor, fostamatinib (R788), recently in-licensed from Rigel Pharmaceuticals, Inc., significantly improved outcomes of patients with rheumatoid arthritis who responded inadequately to ongoing treatment with methotrexate, according to phase II study data published in The New England Journal of Medicine today.
› Verified 1 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 10.95 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 7.64 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 37.12 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 5.59 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 1.76 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 5.17 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0.11 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 3.63 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 98.46 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 51.57 | 14.2 |